Blood, Saliva Tests May Help ID Head and Neck Cancers Early
This sort of research has been going on for years with various tumors and tumor products and frequently it has been difficult to show that finding the tumor cell or cancer cell product when no tumor was apparent anywhere often was either not the case or did not make an overall difference in various measures such as diagnostic evaluation, prognoses, treatment recommendations, remission rates or response rates or cures . However , that is NOT true for all cancers all of the time DR RYAN
Study shows potential for noninvasive tumor detection
FRIDAY, June 26, 2015 (HealthDay News) — Scientists report they’ve detected DNA from head and neck cancer tumors in patients’ blood and saliva samples, a development that potentially could lead to early diagnosis of these malignancies. The finding was published in the June 24 issue of Science Translational Medicine.
For the study, Nishant Agrawal, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues obtained saliva samples from 93 patients newly diagnosed with head and neck cancer or with recurrent cancer. Forty-seven also gave blood samples.
The researchers detected tumor DNA in the saliva of 71 patients (76 percent) and in the blood of 41 patients (87 percent). In 45 of the 47 patients who gave both blood and saliva, investigators were able to identify tumor DNA in at least one of the fluids. Specifically, Agrawal and colleagues searched blood and saliva for traces of human papillomavirus (HPV), which accounts for a growing number of these cancers. For cancers not related to HPV, they looked for mutations in specific cancer-related genes. The saliva tests were better at identifying cancers in the mouth, while blood tests detected more cancers in the throat. Combining the two could help identify cancers anywhere in this region, Agrawal told HealthDay. ( This is unproven conjecture at this point)
If the test were to become routinely used, Agrawal expects it would cost several hundred dollars, although he’d like to see it priced at less than $50 and given by doctors and dentists. “More study is necessary to validate the findings in larger groups of patients and healthy people, improve the test performance, and define the precise indications for the test,” he added.